Effectiveness of the Selective Serotonin Reuptake Inhibitor,Citalopram (Cipralex), in Prurigo Nodularis
|ClinicalTrials.gov Identifier: NCT00532519|
Recruitment Status : Unknown
Verified September 2007 by Hadassah Medical Organization.
Recruitment status was: Not yet recruiting
First Posted : September 20, 2007
Last Update Posted : September 20, 2007
Prurigo nodularis (PN) is a common dermatological disorder, manifested as scaly nodules which appear mainly on the extensor surfaces of the limbs. PN may appear secondarily to skin scratching in chronic hepatitis, liver cirrhosis, uremia, hypothyroidism etc. Nevertheless, in many cases no underlying physical disease is present. According to the literature, in fifty percent of the patients there is co-morbidity with depression, anxiety or somatoform disorders.
We hypothesize that a group of these patients may benefit from antidepressant therapy.
|Condition or disease||Intervention/treatment|
|Prurigo Nodularis||Drug: citalopram (cipralex)|
|Study Type :||Interventional (Clinical Trial)|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
Drug: citalopram (cipralex)
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00532519
|Contact: Liran Horev, MD||OO97226777111||LIRAN_CH@BEZEQINT.NET|
|: Hadassah Medical Organization,||Not yet recruiting|
|Contact: Arik Tzukert, DMD 00 972 2 6776095 firstname.lastname@example.org|
|Contact: Hadas Lemberg, PhD 00 972 2 6777572 : email@example.com|
|Principal Investigator:||liran horev, md||Hadassah Medical Organization|
|Principal Investigator:||rena cooper-kazaz, md||Hadassah Medical Organization|